[TOP STORY] GLP-1: A threat to fast-food and associated medical intervention businesses?

Loading player...
Ross Yammin from Laurium Capital dips into the opportunities and threats possibly posed by Novo and Lilly’s ‘wonder’ drug.
8 Mar 2024 2AM English South Africa Business News · Business

Other recent episodes

Spur with a taste for dividends

Analysis of Spur’s strong results against a tougher performance from Exxaro and the opportunities that shifting market regimes are creating for active investors.
21 Aug 1AM 19 min